Sarepta Gene Therapy Suspension - Search News

Order byBest matchMost fresh

News

Sarepta Shares Slide Again

· 3d · on MSN

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Shares of drugmaker Sarepta Therapeutics continued to fall Tuesday after the company said it would comply with a Food and Drug Administration request to pause shipments of its gene therapy following several patient deaths.

Continue reading

· 3d · on MSN

In a reversal, Sarepta says it will pause shipments of gene therapy linked to deaths

Fierce Pharma · 3d

Sarepta, bowing to FDA pressure, pauses shipments of Duchenne gene therapy Elevidys

Following Sarepta’s Lead, Roche Suspends Elevidys Shipments to Some Ex-US Countries

Discovered and developed by Sarepta Therapeutics, Elevidys is a gene therapy that won accelerated approval in June 2023 and ...

Fierce Pharma2d

Roche halts Elevidys distribution in some countries, following Sarepta's lead in US

Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results